OPKO Health Inc (OPK) - Financial and Strategic SWOT Analysis Review

  • ID: 4319046
  • SWOT Analysis
  • 51 pages
  • GlobalData
  • OPKO Health Inc
1 of 5

FEATURED COMPANIES

  • Genentech Inc
  • Merck & Co Inc
  • Novartis AG
  • Quest Diagnostics Inc
  • Siemens Healthcare GmbH
  • MORE
OPKO Health Inc (OPK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

OPKO Health Inc (OPKO) is a biopharmaceutical and diagnostic company. It discovers, develops, manufactures and commercializes novel diagnostic technologies and pharmaceuticals. The company’s product portfolio includes point-of-care tests, laboratory developed tests (LDTs), molecular diagnostics tests, and proprietary pharmaceuticals and vaccines. It offers products and vaccines that are used in the treatment of chronic kidney disease, Parkinson’s disease, asthma, hemophilia, obesity, chronic obstructive pulmonary disease (COPD) and chemotherapy-induced nausea and vomiting, among others. The company also offers contract research services to other pharmaceutical companies. The company has its operational presence with its offices located in Chile, Mexico, Spain, Ireland, Canada and Israel. OPKO is headquartered in Miami, Florida, the US.

OPKO Health Inc Key Recent Developments

Jun 22,2017: OPKO Health Announces KDIGO Clinical Practice Guideline Update on CKD-MBD
May 09,2017: OPKO Health Reports 2016 Financial and Operating Results
Mar 03,2017: OPKO Health Appoints Dr. Akhtar Ashfaq as Renal Division Senior Vice President, Clinical Research and Development
Mar 01,2017: OPKO Health Reports 2016 Financial and Operating Results
Feb 28,2017: OPKO Health's GeneDx Announces Participation in Illumina's iHope Program on International Rare Disease Day

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Genentech Inc
  • Merck & Co Inc
  • Novartis AG
  • Quest Diagnostics Inc
  • Siemens Healthcare GmbH
  • MORE
Section 1 - About the Company
OPKO Health Inc - Key Facts
OPKO Health Inc - Key Employees
OPKO Health Inc - Key Employee Biographies
OPKO Health Inc - Major Products and Services
OPKO Health Inc - History
OPKO Health Inc - Company Statement
OPKO Health Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis
OPKO Health Inc - Business Description
OPKO Health Inc - Corporate Strategy
OPKO Health Inc - SWOT Analysis
SWOT Analysis - Overview
OPKO Health Inc - Strengths
OPKO Health Inc - Weaknesses
OPKO Health Inc - Opportunities
OPKO Health Inc - Threats
OPKO Health Inc - Key Competitors

Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances
OPKO Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
OPKO Health Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
OPKO Health Inc, Recent Deals Summary

Section 5 - Company’s Recent Developments
Jun 22, 2017: OPKO Health Announces KDIGO Clinical Practice Guideline Update on CKD-MBD
May 09, 2017: OPKO Health Reports 2016 Financial and Operating Results
Mar 03, 2017: OPKO Health Appoints Dr. Akhtar Ashfaq as Renal Division Senior Vice President, Clinical Research and Development
Mar 01, 2017: OPKO Health Reports 2016 Financial and Operating Results
Feb 28, 2017: OPKO Health's GeneDx Announces Participation in Illumina's iHope Program on International Rare Disease Day
Dec 19, 2016: OPKO Health to be Added to the NASDAQ Biotechnology Index
Nov 07, 2016: OPKO Health Reports Third Quarter Financial and Operating Results
Sep 27, 2016: OPKO Health Appoints Dr. Benjamin Solomon as Managing Director of GeneDx
Sep 13, 2016: OPKO Health Appoints Jane Pine Wood as Chief Legal and Compliance Officer of BioReference Laboratories
Aug 08, 2016: OPKO Health Reports Improved Financial and Operating Results

Section 6 - Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables:
OPKO Health Inc, Key Facts
OPKO Health Inc, Key Employees
OPKO Health Inc, Key Employee Biographies
OPKO Health Inc, Major Products and Services
OPKO Health Inc, History
OPKO Health Inc, Other Locations
OPKO Health Inc, Subsidiaries
OPKO Health Inc, Key Competitors
OPKO Health Inc, Ratios based on current share price
OPKO Health Inc, Annual Ratios
OPKO Health Inc, Annual Ratios (Cont...1)
OPKO Health Inc, Interim Ratios
OPKO Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
OPKO Health Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
OPKO Health Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures:
OPKO Health Inc, Performance Chart (2012 - 2016)
OPKO Health Inc, Ratio Charts
OPKO Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
OPKO Health Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Siemens Healthcare GmbH
  • Quest Diagnostics Inc
  • Novartis AG
  • Merck & Co Inc
  • Laboratory Corp of America Holdings
  • Genentech Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll